Sumitomo Mitsui Trust Group Inc. Sells 425 Shares of United Therapeutics Co. (NASDAQ:UTHR)
Sumitomo Mitsui Trust Group Inc. lessened its holdings in United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 0.4% during the 3rd quarter, according to its most recent filing with the Securities ...
Liquidia Corporation: Resilience In The Face Of Formidable Opposition Can Pay Off
Liquidia's collaboration on L606 boosts long-term growth potential. Find out why LQDA stock’s valuation and upcoming launches ...
United Therapeutics: One To Believe In Despite Competitive Threats
United Therapeutics' pipeline and Tyvaso DPI drive strong growth. Read why UTHR stock offers substantial upside with ...
Liquidia Corporation (NASDAQ:LQDA) Q3 2024 Earnings Call Transcript
Q3 2024 Earnings Call Transcript November 13, 2024 Operator: Good morning and welcome everyone to Liquidia Corporation Third ...
ETF Daily News3d
Axxcess Wealth Management LLC Invests $435,000 in United Therapeutics Co. (NASDAQ:UTHR)
The company offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat ...
Liquidia Corporation Reports Third Quarter 2024 Financial Results And Provides Corporate Update
Received tentative approval from the FDA for YUTREPIATM (treprostinil) inhalation powder for both pulmonary arterial hypertension (PAH) ...